Skip to main content
Clinical Trials/NCT05236881
NCT05236881
Completed
Not Applicable

Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 site in 1 country36 target enrollmentApril 20, 2022
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment
36
Locations
1
Primary Endpoint
%TWL at 4 months
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity.

The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring.

Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).

Registry
clinicaltrials.gov
Start Date
April 20, 2022
End Date
January 31, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years of age.
  • People with BMI 30-39.9 kg/m
  • Have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and have sufficient capabilities to use it.
  • Have access to a scale for regular weight monitoring.

Exclusion Criteria

  • Presence of serious major comorbidities: High blood pressure treated with \> 3 drugs, diabetes mellitus treated with insulin, dyslipidemia treated with PCSK9 inhibitors, sleep apnea-hypopnea syndrome treated with CPAP, ischemic heart disease or stroke.
  • Use of pharmacological treatment with influence on weight started in the 6 months prior to study entry.
  • History of weight loss intervention (diet, exercise) in the 6 months prior to study entry.
  • History of eating disorder.
  • History of bariatric surgery.
  • Use of any other app or treatment to lose weight in the 6 months prior to study entry.
  • Pregnancy, short-term gestational desire or lactation.
  • Any other disease or condition that may interfere with compliance with the protocol or completion of the study.

Outcomes

Primary Outcomes

%TWL at 4 months

Time Frame: 4 months

Percentage of total weight loss (%TWL) at 4 months

Secondary Outcomes

  • %TWL at 2 months(2 months)
  • %EWL at 2 and 4 months(2 and 4 months)
  • BMI change at 2 and 4 months(Baseline, 2 and 4 months)
  • Waist change at 2 and 4 months(Baseline, 2 and 4 months)
  • Blood pressure change at 2 and 4 months(Baseline, 2 and 4 months)
  • HbA1c change at 2 and 4 months(Baseline, 2 and 4 months)
  • Mediterranean diet adherence change at 4 months(Baseline and 4 months)
  • IPAQ change at 4 months(Baseline and 4 months)
  • ACTA change at 4 months(Baseline and 4 months)
  • Adherence to records(2 and 4 months)
  • Adherence to recommendations(2 and 4 months)
  • Adherence to visits(2 and 4 months)
  • Adherence to the app(2 months after the end of the study)
  • Quality of life change at 4 months(Baseline and 4 months)
  • Satisfaction with the app(4 months)

Study Sites (1)

Loading locations...

Similar Trials